{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:06:58Z","timestamp":1790795218777,"version":"4.1.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1998,2,1]],"date-time":"1998-02-01T00:00:00Z","timestamp":886291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[1998,2]]},"DOI":"10.1006\/rtph.1997.1163","type":"journal-article","created":{"date-parts":[[2002,10,7]],"date-time":"2002-10-07T14:37:46Z","timestamp":1034001466000},"page":"47-60","source":"Crossref","is-referenced-by-count":178,"title":["Do Peroxisome Proliferating Compounds Pose a Hepatocarcinogenic Hazard to Humans?"],"prefix":"10.1006","volume":"27","author":[{"given":"Russell C.","family":"Cattley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"DeLuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cliff","family":"Elcombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Fenner-Crisp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Lake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Marsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy A.","family":"Pastoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Popp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise E.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Schwetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Tugwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Wahli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/rtph.1997.1163_RT971163RF1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1177\/096032719401300201","article-title":"Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis","volume":"13","author":"Ashby","year":"1994","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1006\/rtph.1997.1163_RT971163RF2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/bbrc.1993.1378","article-title":"PPAR\u2013RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene","volume":"193","author":"Bardot","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/rtph.1997.1163_RT971163RF3","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/carcin\/14.7.1451","article-title":"Comparison of the acute and chronic mitogenic effects of the peroxisome proliferator methylclofenapate and clofibric acid in rat liver","volume":"14","author":"Barrass","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1006\/rtph.1997.1163_RT971163RF4","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/0278-6915(93)90225-N","article-title":"Hepatic peroxisome proliferation in rodents and its significance for humans","volume":"31","author":"Bentley","year":"1993","journal-title":"Food Chem. Toxicol."},{"key":"10.1006\/rtph.1997.1163_RT971163RF5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1006\/taap.1995.1164","article-title":"Effects of ammonium perfluorooctanoate on leydig cell function:In vitro, in vivo,ex vivo","volume":"134","author":"Biegel","year":"1995","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1006\/rtph.1997.1163_RT971163RF6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0021-9150(83)90169-7","article-title":"Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic patients","volume":"46","author":"Blumcke","year":"1983","journal-title":"Atherosclerosis"},{"key":"10.1006\/rtph.1997.1163_RT971163RF7","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1210\/endo.137.1.8536636","article-title":"Differential expression of peroxisome proliferator-activated receptors (PPARS)\u2014Tissue distribution of PPAR-\u03b1, -\u03b2, and -\u03b3 in the adult rat","volume":"137","author":"Braissant","year":"1996","journal-title":"Endocrinology"},{"key":"10.1006\/rtph.1997.1163_RT971163RF8","first-page":"47 P-14","article-title":"Toxicokinetics of gemfibrozil in rats, mice and hamsters","volume":"VII","author":"Buchanan","year":"1995","journal-title":"Int. Toxicologist"},{"key":"10.1006\/rtph.1997.1163_RT971163RF9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/carcin\/5.4.453","article-title":"Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters","volume":"5","author":"Bursch","year":"1984","journal-title":"Carcinogenesis"},{"key":"10.1006\/rtph.1997.1163_RT971163RF10","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1093\/carcin\/14.12.2495","article-title":"Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferator-relationship to carcinogenesis and nuclear localization","volume":"14","author":"Cattley","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1006\/rtph.1997.1163_RT971163RF11","first-page":"3246","article-title":"Differences in the promoting activities of the peroxisome proliferator Wy-14,643 and phenobarbital in rat liver","volume":"49","author":"Cattley","year":"1989","journal-title":"Cancer Res."},{"key":"10.1006\/rtph.1997.1163_RT971163RF12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/carcin\/12.3.469","article-title":"Age-related susceptibility to the carcinogenic effect of the peroxisome proliferation Wy-14,643 in rat liver","volume":"12","author":"Cattley","year":"1991","journal-title":"Carcinogenesis"},{"key":"10.1006\/rtph.1997.1163_RT971163RF13","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.1073\/pnas.92.15.7080","article-title":"Transformation of mammalian cells by overexpressing H22","volume":"92","author":"Chu","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/rtph.1997.1163_RT971163RF14","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0015-6264(81)90509-5","article-title":"Review of the hepatic response to hypolipidaemic drugs in rodents and assessment of its toxicological significance to man","volume":"19","author":"Cohen","year":"1981","journal-title":"Food Chem. Toxicol."},{"key":"10.1006\/rtph.1997.1163_RT971163RF15","first-page":"47-P-13","article-title":"Toxicokinetics (TK) of di-n","volume":"VII","author":"Collins","year":"1995","journal-title":"Int. Toxicologist"},{"key":"10.1006\/rtph.1997.1163_RT971163RF16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/carcin\/10.3.513","article-title":"Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di (2-ethylhexyl)phthalate and Wy-14,643","volume":"3","author":"Conway","year":"1989","journal-title":"Carcinogenesis"},{"key":"10.1006\/rtph.1997.1163_RT971163RF17","first-page":"1157","article-title":"Rat 17\u03b2-hydroxysteroid dehydrogenase type IV is a novel peroxisome proliferator-inducible gene","volume":"50","author":"Corton","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1006\/rtph.1997.1163_RT971163RF18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0021-9150(82)90096-X","article-title":"Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatment","volume":"43","author":"De La Iglesia","year":"1982","journal-title":"Atherosclerosis"},{"key":"10.1006\/rtph.1997.1163_RT971163RF19","series-title":"Inducible Transcription","article-title":"PPAR: A key factor in nutrient\/gene interactions","author":"Desvergne","year":"1995"},{"key":"10.1006\/rtph.1997.1163_RT971163RF20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/384039a0","article-title":"The PPAR\u03b1\u2013leukotriene B4 pathway to inflammation control","volume":"384","author":"Devchand","year":"1996","journal-title":"Nature"},{"key":"10.1006\/rtph.1997.1163_RT971163RF21","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0092-8674(92)90031-7","article-title":"Control of the peroxisome beta oxidation pathway by a novel family of nuclear hormone receptors","volume":"68","author":"Dreyer","year":"1992","journal-title":"Cell"},{"key":"10.1006\/rtph.1997.1163_RT971163RF22","first-page":"47-P-4","article-title":"Differential enzyme inducing activity of peroxisome proliferators in the male syrian hamster","volume":"VII","author":"Durnford","year":"1995","journal-title":"Int. Toxicologist"},{"key":"10.1006\/rtph.1997.1163_RT971163RF23","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/carcin\/12.9.1557","article-title":"Hepatocellular DNA synthesis in rats given peroxisome proliferating agents\u2014comparison of Wy-14,643 to clofibric acid, nafenopin and LY171883","volume":"12","author":"Eacho","year":"1991","journal-title":"Carcinogenesis"},{"key":"10.1006\/rtph.1997.1163_RT971163RF24","first-page":"63","article-title":"Species differences in peroxisome proliferation","volume":"9","author":"Elcombe","year":"1989","journal-title":"Toxicologist"},{"key":"10.1006\/rtph.1997.1163_RT971163RF25","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1749-6632.1996.tb18649.x","article-title":"Peroxisome Proliferators: Species differences in response of primary hepatocyte cultures","volume":"804","author":"Elcombe","year":"1997","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1006\/rtph.1997.1163_RT971163RF26","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0092-8674(95)90193-0","article-title":"15-Deoxy-delta(12,14)-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR-gamma","volume":"83","author":"Forman","year":"1995","journal-title":"Cell"},{"key":"10.1006\/rtph.1997.1163_RT971163RF27","first-page":"47-P-5","article-title":"Liver protein changes in B6C3F1 mice and Syrian hamsters treated with the peroxisome proliferator Wy-14,643","volume":"VII","author":"Giometti","year":"1995","journal-title":"Int. Toxicologist"},{"key":"10.1006\/rtph.1997.1163_RT971163RF28","first-page":"1324","article-title":"Peroxisome proliferators and lipid peroxidation in rat liver","volume":"46","author":"Goel","year":"1986","journal-title":"Cancer Res."},{"key":"10.1006\/rtph.1997.1163_RT971163RF29","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/carcin\/14.5.1007","article-title":"Enhancement of peroxisomal enzymes, cytochrome p450 and DNA syntheses in putative preneoplastic foci of rat liver treated with the peroxisome proliferator nafenopin","volume":"14","author":"Grasl-Kraupp","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1006\/rtph.1997.1163_RT971163RF30","first-page":"47-P-9","article-title":"Toxicokinetics (TK) of 2,4-dichlorophenoxyacetic acid (2,4-D) in rats, mice and hamsters","volume":"VII","author":"Grizzle","year":"1995","journal-title":"Int. Toxicologist"},{"key":"10.1006\/rtph.1997.1163_RT971163RF31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0021-9150(80)90225-7","article-title":"Effects ofp","volume":"36","author":"Hanefeld","year":"1980","journal-title":"Atherosclerosis"},{"key":"10.1006\/rtph.1997.1163_RT971163RF32","doi-asserted-by":"crossref","first-page":"13470","DOI":"10.1074\/jbc.270.22.13470","article-title":"Mode of action of peroxisome proliferators as hypolipidemic drugs","volume":"270","author":"Hertz","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1006\/rtph.1997.1163_RT971163RF33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jbt.2570100503","article-title":"Effect of phenobarbital and the peroxisome proliferator ciprofibrate on glutamyltranspeptidase activity and leukotriene C4 concentration in cultured rat hepatocytes","volume":"10","author":"Hong","year":"1995","journal-title":"J. Biochem. Toxicol."},{"key":"10.1006\/rtph.1997.1163_RT971163RF34","year":"1995","journal-title":"IARC Technical Report No. 24"},{"key":"10.1006\/rtph.1997.1163_RT971163RF35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1677\/jme.0.0110037","article-title":"The PPAR:RXR heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs","volume":"11","author":"Issemann","year":"1993","journal-title":"J. Mol. Endocrinol."},{"key":"10.1006\/rtph.1997.1163_RT971163RF36","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1093\/carcin\/17.8.1623","article-title":"Species differences in response to peroxisome proliferators correlatein vitro","volume":"17","author":"James","year":"1996","journal-title":"Carcinogenesis"},{"key":"10.1006\/rtph.1997.1163_RT971163RF37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1432-1033.1995.219_1.x","article-title":"Chromosomal localisation, inducibility, tissue-specific expression and strain differences in three murine peroxisome proliferator-activated receptor genes","volume":"233","author":"Jones","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"10.1006\/rtph.1997.1163_RT971163RF38","first-page":"2603","article-title":"Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator","volume":"49","author":"Kasai","year":"1989","journal-title":"Cancer Res."},{"key":"10.1006\/rtph.1997.1163_RT971163RF39","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1073\/pnas.90.6.2160","article-title":"Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor\u2013retinoid X receptor heterodimers","volume":"90","author":"Keller","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/rtph.1997.1163_RT971163RF40","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/358771a0","article-title":"Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors","volume":"358","author":"Kliewer","year":"1992","journal-title":"Nature"},{"key":"10.1006\/rtph.1997.1163_RT971163RF41","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0092-8674(95)90194-9","article-title":"A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation","volume":"83","author":"Kliewer","year":"1995","journal-title":"Cell"},{"key":"10.1006\/rtph.1997.1163_RT971163RF42","first-page":"3701","article-title":"Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver","volume":"50","author":"Kraupp-Grasl","year":"1990","journal-title":"Cancer Res."},{"key":"10.1006\/rtph.1997.1163_RT971163RF43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0300-483X(87)90151-X","article-title":"Effect of prolonged administration of clofibric acid and di-(2-ethylhexyl) phthalate of hepatic enzyme activities and lipid peroxidation in the rat","volume":"44","author":"Lake","year":"1987","journal-title":"Toxicology"},{"key":"10.1006\/rtph.1997.1163_RT971163RF44","first-page":"241","article-title":"Comparison of the hepatic effects of nafenopin and Wy-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster","volume":"101","author":"Lake","year":"1993","journal-title":"Environ. Health Perspect."},{"key":"10.1006\/rtph.1997.1163_RT971163RF45","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.pa.35.040195.002411","article-title":"Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals","volume":"35","author":"Lake","year":"1995","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1006\/rtph.1997.1163_RT971163RF46","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0378-4274(95)03513-3","article-title":"Peroxisome proliferation: Current mechanisms relating to non-genotoxic carcinogenesis","volume":"82\/83","author":"Lake","year":"1995","journal-title":"Toxicol. Lett."},{"key":"10.1006\/rtph.1997.1163_RT971163RF47","first-page":"241","article-title":"Species differences in hepatic peroxisome proliferation, cell replication and transforming growth factor-\u03b21 (TFG-\u03b21) gene expression","volume":"15","author":"Lake","year":"1995","journal-title":"Toxicologist"},{"key":"10.1006\/rtph.1997.1163_RT971163RF48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1996.0001u.x","article-title":"A human peroxisome-proliferation-activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs","volume":"239","author":"Lambe","year":"1996","journal-title":"Eur. J. Biochem."},{"key":"10.1006\/rtph.1997.1163_RT971163RF49","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1128\/MCB.15.6.3012","article-title":"Targeted disruption of the \u03b1 isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators","volume":"15","author":"Lee","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1006\/rtph.1997.1163_RT971163RF50","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","article-title":"An antidiabetic thiazolidinedione is a high affinity ligand for the nuclear receptor PPAR\u03b3","volume":"270","author":"Lehmann","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1006\/rtph.1997.1163_RT971163RF51","doi-asserted-by":"crossref","first-page":"24527","DOI":"10.1016\/S0021-9258(17)31420-5","article-title":"Regulation of the peroxisome proliferator-activated receptor \u03b1 gene by glucocorticoids","volume":"269","author":"Lemberger","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1006\/rtph.1997.1163_RT971163RF52","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1074\/jbc.271.3.1764","article-title":"Expression of the peroxisome proliferator-activated receptor \u03b1 gene is stimulated by stress and follows a diurnal rhythm","volume":"271","author":"Lemberger","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1006\/rtph.1997.1163_RT971163RF53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0378-4274(96)03639-9","article-title":"Reduction of the concentrations of prostaglandins e-2 and f-e alpha, and thromboxane b-2 in cultured rat hepatocytes treated with the peroxisome proliferator ciprofibrate","volume":"85","author":"Leung","year":"1996","journal-title":"Toxicol. Lett."},{"key":"10.1006\/rtph.1997.1163_RT971163RF54","first-page":"160","article-title":"NF-\u03baB activity is increased by the peroxisome proliferator ciprofibrate in rats","volume":"37","author":"Li","year":"1996","journal-title":"Proc. AACR"},{"key":"10.1006\/rtph.1997.1163_RT971163RF55","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.pa.29.040189.001045","article-title":"Biochemical mechanisms of induction of hepatic peroxisome proliferation","volume":"29","author":"Lock","year":"1989","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1006\/rtph.1997.1163_RT971163RF56","first-page":"6739","article-title":"Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats","volume":"48","author":"Marsman","year":"1988","journal-title":"Cancer Res."},{"key":"10.1006\/rtph.1997.1163_RT971163RF57","series-title":"Peroxisome Proliferator Hepatocarcinogenesis in Rats","author":"Marsman","year":"1991"},{"key":"10.1006\/rtph.1997.1163_RT971163RF58","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/carcin\/13.6.1011","article-title":"Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid","volume":"15","author":"Marsman","year":"1992","journal-title":"Carcinogenesis"},{"key":"10.1006\/rtph.1997.1163_RT971163RF59","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1539-6924.1994.tb00247.x","article-title":"Apoptosis and chemical carcinogenesis","volume":"14","author":"Marsman","year":"1994","journal-title":"Risk Anal."},{"key":"10.1006\/rtph.1997.1163_RT971163RF60","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/carcin\/15.1.111","article-title":"Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14,643","volume":"15","author":"Marsman","year":"1994","journal-title":"Carcinogenesis"},{"key":"10.1006\/rtph.1997.1163_RT971163RF61","first-page":"47-P-11","article-title":"Toxicokinetics (TK) of the peroxisome proliferator Wy-14,643 in rats, mice and hamsters","volume":"VII","author":"Marsman","year":"1995","journal-title":"Int. Toxicologist"},{"key":"10.1006\/rtph.1997.1163_RT971163RF62","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/carcin\/17.6.1337","article-title":"Effect on the expression of c-met, c-myc and PPAR-alpha in liver and liver tumors from rats chronically exposed to the hepatocarcinogenic peroxisome proliferator Wy-14,643","volume":"17","author":"Miller","year":"1996","journal-title":"Carcinogenesis"},{"key":"10.1006\/rtph.1997.1163_RT971163RF63","first-page":"160","article-title":"Characterization of regressing peroxisome proliferator-induced hepatocellular adenomas","volume":"37","author":"Miller","year":"1996","journal-title":"Proc. AACR"},{"key":"10.1006\/rtph.1997.1163_RT971163RF64","doi-asserted-by":"crossref","first-page":"19169","DOI":"10.1016\/S0021-9258(19)36491-9","article-title":"Chicken ovalbumin upstream promoter transcription factor (COUP-TF) binds to a peroxisome proliferator responsive element and antagonises peroxisome proliferator mediated signalling","volume":"268","author":"Miyata","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1006\/rtph.1997.1163_RT971163RF65","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0272-0590(91)90108-G","article-title":"Peroxisome proliferation and nongenotoxic carcinogenesis: Commentary on a symposium","volume":"16","author":"Moody","year":"1991","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1006\/rtph.1997.1163_RT971163RF66","first-page":"5316","article-title":"Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissue of rat","volume":"48","author":"Nemali","year":"1988","journal-title":"Cancer Res."},{"key":"10.1006\/rtph.1997.1163_RT971163RF67","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0041-008X(89)90056-2","article-title":"Defferential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens","volume":"97","author":"Nemali","year":"1989","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1006\/rtph.1997.1163_RT971163RF68","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0041-008X(84)90062-0","article-title":"Clobuzarit: Species differences in the morphological and biochemical response of the liver following chronic administration","volume":"73","author":"Orton","year":"1984","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1006\/rtph.1997.1163_RT971163RF69","doi-asserted-by":"crossref","first-page":"18083","DOI":"10.1016\/S0021-9258(17)32420-1","article-title":"Interaction of the peroxisome proliferator-activated receptor \u03b1 with the retinoid X receptor \u03b1 unmasks a cryptic peroxisome proliferator response element that overlaps an ARP-1-binding site in the CYP4A6 promoter","volume":"269","author":"Palmer","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1006\/rtph.1997.1163_RT971163RF70","first-page":"1143","article-title":"Testing for induction of DNA synthesis in human hepatocyte primary cultures by rat liver tumor promoters","volume":"51","author":"Parzefall","year":"1991","journal-title":"Cancer Res."},{"key":"10.1006\/rtph.1997.1163_RT971163RF71","doi-asserted-by":"crossref","DOI":"10.1093\/carcin\/18.11.2029","article-title":"Role of PPAR-\u03b1 in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643","author":"Peters","year":"1997","journal-title":"Carcinogenesis"},{"key":"10.1006\/rtph.1997.1163_RT971163RF72","series-title":"Peroxisomes: Biology and Importance in Toxicology and Medicine","first-page":"653","article-title":"Peroxisome proliferators as initiators and promoters of rodent hepatocarcinogenesis","author":"Popp","year":"1993"},{"key":"10.1006\/rtph.1997.1163_RT971163RF73","first-page":"4","article-title":"Hepatic peroxisome proliferation: Induction by BR-931, a hypolipidemic analog of Wy-14,643","volume":"234","author":"Reddy","year":"1978","journal-title":"Arch. Int. Pharmacodyn."},{"key":"10.1006\/rtph.1997.1163_RT971163RF74","first-page":"152","article-title":"Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643), in rat and mouse liver","volume":"39","author":"Reddy","year":"1979","journal-title":"Cancer Res."},{"key":"10.1006\/rtph.1997.1163_RT971163RF75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408448309029317","article-title":"Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans","volume":"12","author":"Reddy","year":"1983","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1006\/rtph.1997.1163_RT971163RF76","first-page":"299","article-title":"Comparative pharmacokinetics and subacute toxicity of di-(2-ethylhexyl)phthalate (DEHP) in rats and marmosets: extrapolation of effects in rodents to man","volume":"65","author":"Rhodes","year":"1986","journal-title":"Environ. Health Perspect."},{"key":"10.1006\/rtph.1997.1163_RT971163RF77","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/carcin\/16.8.1693","article-title":"Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations","volume":"16","author":"Roberts","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1006\/rtph.1997.1163_RT971163RF78","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/074823378700300214","article-title":"Interspecies difference in peroxisomes and peroxisome proliferation","volume":"3","author":"Rodricks","year":"1987","journal-title":"Toxicol. Ind. Health"},{"key":"10.1006\/rtph.1997.1163_RT971163RF79","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/carcin\/16.8.1795","article-title":"Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: Relationship to mitochondrial alterations","volume":"16","author":"Sausen","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1006\/rtph.1997.1163_RT971163RF80","first-page":"1634","article-title":"Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids","volume":"6","author":"Schmidt","year":"1992","journal-title":"Mol. Endocrinol."},{"key":"10.1006\/rtph.1997.1163_RT971163RF81","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1021\/bi00072a015","article-title":"cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor","volume":"32","author":"Sher","year":"1993","journal-title":"Biochemistry"},{"key":"10.1006\/rtph.1997.1163_RT971163RF82","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0273-2300(88)90026-8","article-title":"Chemically induced proliferation of peroxisomes: Implications for risk assessment","volume":"8","author":"Stott","year":"1988","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1006\/rtph.1997.1163_RT971163RF83","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/carcin\/9.9.1647","article-title":"A species comparison of acute hyperplasia induced by the peroxisome proliferator methylclofenapate: Involvement of the binucleated hepatocyte","volume":"9","author":"Styles","year":"1988","journal-title":"Carcinogenesis"},{"key":"10.1006\/rtph.1997.1163_RT971163RF84","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/carcin\/11.3.387","article-title":"Effects produced by the non-genotoxic hepatocarcinogen methylclofenapate in dwarf mice: Peroxisome induction uncoupled from DNA synthesis and nuclearity changes","volume":"11","author":"Styles","year":"1990","journal-title":"Carcinogenesis"},{"key":"10.1006\/rtph.1997.1163_RT971163RF85","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0304-3835(90)90007-K","article-title":"Relationship between hepatic peroxisome proliferation and 8-hydroxydeoxyguanosine formation in liver DNA of rats following long-term exposure to three peroxisome proliferators: di(2-ethylhexyl) phthalate, aluminium clofibrate and simfibrate","volume":"53","author":"Takagi","year":"1990","journal-title":"Cancer Lett."},{"key":"10.1006\/rtph.1997.1163_RT971163RF86","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0041-008X(92)90146-J","article-title":"Studies of early hepatocellular proliferation and peroxisomal proliferation in Sprague-Dawley rats treated with tumorigenic doses of clofibrate","volume":"116","author":"Tanaka","year":"1992","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1006\/rtph.1997.1163_RT971163RF87","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1101\/gad.8.10.1224","article-title":"MPPAR-gamma2: Tissue-specific regulator of an adipocyte enhancer","volume":"8","author":"Tontonoz","year":"1994","journal-title":"Genes Dev."},{"key":"10.1006\/rtph.1997.1163_RT971163RF88","series-title":"Comparative Toxicology of Hypolipidaemic fibrates","author":"Tucker","year":"1995"},{"key":"10.1006\/rtph.1997.1163_RT971163RF89","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/j.1460-2075.1992.tb05072.x","article-title":"The mouse peroxisome proliferator activated receptor recognizes a response element in the 5\u2032 flanking region of the rat acyl CoA oxidase gene","volume":"11","author":"Tugwood","year":"1992","journal-title":"EMBO J."},{"key":"10.1006\/rtph.1997.1163_RT971163RF90","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1749-6632.1996.tb18620.x","article-title":"Peroxisome proliferator activated-receptor: Structures and functions","volume":"804","author":"Tugwood","year":"1997","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1006\/rtph.1997.1163_RT971163RF91","doi-asserted-by":"crossref","first-page":"31012","DOI":"10.1016\/S0021-9258(18)47383-8","article-title":"Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element","volume":"269","author":"Vu-Dac","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1006\/rtph.1997.1163_RT971163RF92","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1172\/JCI118118","article-title":"Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor","volume":"96","author":"Vu-Dac","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1006\/rtph.1997.1163_RT971163RF93","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0272-0590(92)90208-Y","article-title":"Dose-related effects of hepatocarcinogen Wy-14,643, on peroxisomes and cell replication","volume":"18","author":"Wada","year":"1992","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1006\/rtph.1997.1163_RT971163RF94","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s002040050203","article-title":"Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid","volume":"69","author":"Wilson","year":"1995","journal-title":"Arch. Toxicol."},{"key":"10.1006\/rtph.1997.1163_RT971163RF95","doi-asserted-by":"crossref","first-page":"7541","DOI":"10.1073\/pnas.89.16.7541","article-title":"Identification of a peroxisome proliferator responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydrates\/3-hydroxyacyl-CoA dehydrogenase","volume":"89","author":"Zhang","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230097911636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230097911636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T06:42:47Z","timestamp":1620024167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230097911636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,2]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,2]]}},"alternative-id":["S0273230097911636"],"URL":"https:\/\/doi.org\/10.1006\/rtph.1997.1163","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[1998,2]]}}}